Article
A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity.
European journal of heart failure - 1 Mar 2013
Friedrich Felix W, Dilanian Gilles, Khattar Patricia, Juhr Denise, Gueneau Lucie, Charron Philippe, Fressart Véronique, Vilquin Jean-Thomas, Isnard Richard, Gouya Laurent, Richard Pascale, Hammoudi Naima, Komajda Michel, Bonne Gisèle, Eschenhagen Thomas, Dubourg Olivier, Villard Eric, Carrier Lucie
Abstract excerpt
AIMS: The transcription factor Islet-1 (ISL1) is a marker of cardiovascular progenitors and is essential for mammalian cardiogenesis. An ISL1 haplotype has recently been associated with congenital heart disease. In this study we evaluated whether ISL1 variants are associated with hypertrophic (HCM), dilated (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), or with Emery-Dreifuss muscular dystrophy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
